An elderly patient has been diagnosed with a cataract. What structure in the eye has become diseased?

Questions 53

ATI RN

ATI RN Test Bank

physical examination and health assessment test bank Questions

Question 1 of 5

An elderly patient has been diagnosed with a cataract. What structure in the eye has become diseased?

Correct Answer: C

Rationale: In this question, the correct answer is C) Lens. In the case of a cataract, the lens of the eye becomes clouded, leading to vision impairment. The lens is responsible for focusing light onto the retina at the back of the eye. Option A) Retina is incorrect because the retina is the layer of tissue at the back of the eye that contains cells sensitive to light and is not typically affected by cataracts. Option B) Cornea is incorrect because the cornea is the clear outermost part of the eye that helps to focus light, but it is not the structure primarily affected by cataracts. Option D) Optic nerve is incorrect because the optic nerve transmits visual information from the retina to the brain and is not directly related to cataracts. Educationally, understanding the anatomy of the eye and common eye conditions like cataracts is essential for healthcare professionals, especially in pharmacology where knowledge of eye disorders and their treatments may be relevant. Identifying the specific structure affected in a condition like cataracts is crucial for accurate diagnosis and treatment planning.

Question 2 of 5

Which condition is associated with end-stage renal disease in pediatric patients and requires recombinant erythropoietin treatment?

Correct Answer: D

Rationale: In pediatric patients with end-stage renal disease, anemia is a common complication due to decreased production of erythropoietin by the damaged kidneys. Recombinant erythropoietin is used to stimulate red blood cell production and treat anemia in these patients. Therefore, the correct answer is D) Anemia. Option A) Osteodystrophy is associated with bone abnormalities in renal disease but does not directly require erythropoietin treatment. Option B) Hyperkalemia is high potassium levels and is managed with dietary restrictions and medications, not erythropoietin. Option C) Hypertension is a common complication of renal disease but is managed with antihypertensive medications. Educationally, understanding the link between renal disease, anemia, and erythropoietin treatment is crucial for healthcare professionals caring for pediatric patients with end-stage renal disease. This knowledge helps in providing appropriate treatment and improving outcomes for these vulnerable patients. It also highlights the importance of monitoring and managing complications associated with renal disease in pediatric populations.

Question 3 of 5

To increase urine outflow in men with BPH, the NP should prescribe:

Correct Answer: A

Rationale: In men with Benign Prostatic Hyperplasia (BPH), the NP should prescribe an alpha blocker to increase urine outflow. Alpha blockers like tamsulosin work by relaxing smooth muscle in the prostate and bladder neck, reducing obstruction and improving urine flow. This class of medication specifically targets the alpha-1 receptors in the prostate, leading to relaxation of the smooth muscle and relieving BPH symptoms. Option A, the alpha blocker, is the correct choice because it directly addresses the underlying cause of decreased urine outflow in BPH. Alpha agonists (Option B) would not be appropriate as they would stimulate alpha receptors and potentially worsen urinary symptoms. Calcium channel blockers (Option C) are not indicated for BPH as they do not target the specific mechanisms involved. Diuretics (Option D) are used to increase urine production but do not address the obstruction caused by BPH. In an educational context, understanding the rationale behind choosing the appropriate medication for BPH is crucial for healthcare providers. It is essential to know the pharmacological mechanisms of action of different drug classes to make informed decisions in patient care. By selecting the correct medication, healthcare providers can effectively manage symptoms, improve patient outcomes, and ensure safe and evidence-based practice in pharmacotherapy.

Question 4 of 5

Which assessment findings are NOT associated with pyloric stenosis in a 2-month-old infant?

Correct Answer: C

Rationale: In the case of pyloric stenosis in a 2-month-old infant, the correct answer is C) A bloated and tense tympanic abdomen. This is because pyloric stenosis typically presents with non-bilious projectile vomiting, visible peristalsis, a palpable "olive-shaped" mass in the right upper quadrant, and signs of dehydration. The bloated and tense tympanic abdomen is not typically associated with pyloric stenosis but may be seen in conditions like intestinal obstruction. Option A) Projectile vomiting is associated with pyloric stenosis due to the obstruction at the pyloric sphincter, causing food to be forcefully expelled. Option B) Severe dehydration with sunken eyeballs and depressed fontanelle is also characteristic of pyloric stenosis due to persistent vomiting leading to fluid and electrolyte imbalances. Option D) A palpable mass the size and shape of an olive in the right upper quadrant is a classic finding in pyloric stenosis due to hypertrophy of the pyloric muscle. Educationally, understanding the typical clinical manifestations of pyloric stenosis is crucial for healthcare providers involved in pediatric care. Recognizing these signs early can lead to prompt diagnosis and intervention, preventing complications associated with delayed treatment. This knowledge is essential for nurses, nurse practitioners, physician assistants, and physicians working in pediatric settings to provide safe and effective care for infants with pyloric stenosis.

Question 5 of 5

Which condition is best treated using alpha-adrenergic antagonist?

Correct Answer: D

Rationale: In pharmacology, alpha-adrenergic antagonists are commonly used to treat conditions like overflow incontinence. Overflow incontinence occurs due to the inability of the bladder to empty completely, often caused by prostatic hyperplasia in males or neurogenic bladder dysfunction. Alpha-adrenergic antagonists help relax the smooth muscle in the bladder neck and prostate, facilitating urine flow and reducing symptoms of overflow incontinence. Option A, functional incontinence, is not typically treated with alpha-adrenergic antagonists. Functional incontinence is usually due to physical or cognitive impairments that hinder one's ability to reach the toilet in time. Option B, renal insufficiency, is a condition related to kidney function and is not directly treated with alpha-adrenergic antagonists. Renal insufficiency requires management aimed at preserving kidney function and addressing underlying causes. Option C, urge incontinence, is often treated with anticholinergic medications to reduce bladder spasms and urge to urinate. Alpha-adrenergic antagonists are not the first-line treatment for urge incontinence. In an educational context, understanding the appropriate use of medications like alpha-adrenergic antagonists is crucial for healthcare professionals, especially in pharmacology and urology. Knowing the specific indications for these drugs helps in providing effective and targeted treatment for patients with conditions like overflow incontinence.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions